Product Program year 2025 Source: CMS Open Payments

mResvia

Drug mResvia

NDC 80777-345-90

Open in the dashboard

General payments

$66,031

72 payments

Research payments

$0

0 payments

Through program year 2025, $66,031 in general payments and $0 in research payments were reported against mResvia (mResvia).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $66,031 72

Breakdown

Who paid General payments · program year 2025
  1. Moderna TX, Inc. $66,031 72 payments
Top recipients General payments · program year 2025
  1. Gregory Poland Internal Medicine · Rochester, MN $14,204 22% · 3 payments
  2. Todd Wolynn Pediatrics · Pittsburgh, PA $5,823 9% · 1 payment
  3. Amesh Adalja Infectious Disease · Pittsburgh, PA $5,591 8% · 2 payments
  4. Resa Bradeen Pediatrics · Happy Valley, OR $4,213 6% · 2 payments
  5. Oluwatosin Goje Obstetrics & Gynecology · Cleveland, OH $4,000 6% · 1 payment

The top 5 of 65 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Internal Medicine $27,109 42% · 14 practitioners
  2. Pediatrics $12,340 19% · 8 practitioners
  3. Infectious Disease Internal Medicine $5,591 9% · 1 practitioner
  4. Pediatric Infectious Diseases Pediatrics $5,381 8% · 2 practitioners
  5. Obstetrics & Gynecology $4,000 6% · 1 practitioner

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $14,571 22% · 3 recipients
  2. Minnesota $14,204 22% · 1 recipient
  3. Oregon $6,432 10% · 2 recipients
  4. Ohio $4,000 6% · 1 recipient
  5. Oklahoma $3,147 5% · 1 recipient

The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

29,819

Prescriptions dispensed, refills included

Drug cost

$9,115,788

Paid at the pharmacy, in all

Prescribers

459

With 11 or more claims of it

Medicare Part D drugs matched to mResvia, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Mresvia Rsv Vaccine, Pref, Mrna/Pf Same name 459 29,819 $9,115,788

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Shaun Gill Hospitalist PA 1,898 $583,061 None on record
Dirk Steinert Internal Medicine WI 1,559 $490,271 None on record
Ruth Mays Family Practice MI 1,028 $305,853 None on record
Daniel Bauer Internal Medicine NC 1,001 $304,171 None on record
Alan Kaufman Pharmacist SC 816 $242,218 No profile

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron
72 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record